Sporadic inclusion body myositis: A review of recent clinical advances and current approaches to diagnosis and treatment

Clinical Neurophysiology : Official Journal of the International Federation of Clinical Neurophysiology
Merrilee Needham, F L Mastaglia

Abstract

Sporadic inclusion body myositis is the most frequent acquired myopathy of middle and later life and is distinguished from other inflammatory myopathies by its selective pattern of muscle involvement and slowly progressive course, and by the combination of inflammatory and degenerative muscle pathology and multi-protein deposits in muscle tissue. This review summarises the findings of recent studies that provide a more complete picture of the clinical phenotype and natural history of the disease and its global prevalence and genetic predisposition. Current diagnostic criteria, including the role of electrophysiological and muscle imaging studies and the recently identified anti-5'-nucleotidase (anti-cN1A) antibody in diagnosis are also discussed as well as current trends in the treatment of the disease.

References

Sep 1, 1983·Neurology·A EisenG Gibson
Nov 1, 1995·Annals of Neurology·R C GriggsL P Rowland
May 1, 1993·The Clinical Investigator·S BeyenburgF Jerusalem
Jan 1, 1997·Neurology·C A Luciano, M C Dalakas
Jan 7, 1998·Journal of Neurology, Neurosurgery, and Psychiatry·T H BrannaganW Trojaborg
Apr 16, 1999·Muscle & Nerve·P E BarkhausS D Nandedkar
Feb 15, 2001·Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America·S OzdenJ Mikol
Aug 31, 2001·Archives of Neurology·R DabbyL P Rowland
Jan 1, 2003·Rheumatic Diseases Clinics of North America·Marinos C Dalakas
Jul 19, 2003·Scandinavian Journal of Immunology·K MüntzingA Oldfors
Jan 26, 2005·Neurology·Miwa TakamureSatoshi Ueno
Jan 25, 2006·Neurology·R J BarohnJ R Mendell
Jul 11, 2006·Muscle & Nerve·Steven A GreenbergAnthony A Amato
Aug 22, 2006·Neuromuscular Disorders : NMD·C LindbergA Oldfors
Jan 12, 2007·The Neurologist·Pedro Enrique Jiménez CaballeroAraceli Alvarez Tejerina
Mar 17, 2007·Muscle & Nerve·M NeedhamM J Garlepp
Jun 22, 2007·Lancet Neurology·Merrilee Needham, Frank L Mastaglia
Dec 28, 2007·Neuromuscular Disorders : NMD·M Needham, F L Mastaglia
Feb 1, 2008·Muscle & Nerve·C E JacksonUNKNOWN Muscle Study Group
Feb 9, 2008·Journal of Neurology, Neurosurgery, and Psychiatry·M NeedhamF L Mastaglia
Sep 26, 2008·Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia·Merrilee NeedhamFrank L Mastaglia
May 21, 2009·Brain : a Journal of Neurology·Marinos C DalakasAllan D Kirk
Jun 6, 2009·Journal of Clinical Neuromuscular Disease·Liam G JohnsonFrank L Mastaglia
Jun 18, 2009·Muscle & Nerve·Mohammad SalajeghehSteven A Greenberg
Jul 16, 2009·Journal of Neurology·F M CoxU A Badrising
Sep 2, 2009·Neuromuscular Disorders : NMD·Frank L MastagliaFrank T Christiansen
Sep 12, 2009·Pacing and Clinical Electrophysiology : PACE·Jordan M Prutkin, Kristen K Patton
Oct 9, 2009·Journal of Neurology·Fieke M CoxUmesh A Badrising
Oct 17, 2009·The Journal of Rheumatology·Rohit AggarwalJohn P Case
Apr 24, 2010·Neuromuscular Disorders : NMD·Olivier Benveniste, David Hilton-Jones
Jan 29, 2011·Gait & Posture·K A BernhardtK R Kaufman
Feb 4, 2011·Rheumatology·Fieke M CoxUmesh A Badrising
Jul 30, 2011·Journal of Neurology·Naoki SuzukiIchizo Nishino
Sep 13, 2011·Brain : a Journal of Neurology·Fieke M CoxUmesh A Badrising
Sep 16, 2011·Acta Neurologica Scandinavica·C Lindberg, A Oldfors
Oct 14, 2011·Brain : a Journal of Neurology·Olivier BenvenisteDavid Hilton-Jones
Dec 23, 2011·Current Opinion in Rheumatology·Helene Alexanderson, Ingrid E Lundberg

❮ Previous
Next ❯

Citations

Oct 21, 2016·Expert Opinion on Therapeutic Patents·Joohun Ha, Joungmok Kim
May 17, 2019·Muscle & Nerve·Gemma CumminsSybil Stacpoole
Aug 24, 2017·Current Opinion in Rheumatology·Karsten Schmidt, Jens Schmidt
Jun 8, 2017·Annals of Clinical and Translational Neurology·Christian W KellerJan D Lünemann
Jan 19, 2019·Advances in Rheumatology·Diego Sales de OliveiraSamuel Katsuyuki Shinjo
Apr 27, 2019·Frontiers in Immunology·Adam AmlaniMarvin J Fritzler
Sep 18, 2020·The Journal of Physiological Sciences : JPS·Yasuo KitajimaNaoki Suzuki
Feb 6, 2020·Frontiers in Neurology·Yu-Ichi NotoMasanori Nakagawa
Aug 7, 2017·International Journal of Rheumatic Diseases·Joana Sousa NevesFilipa Teixeira
Sep 30, 2017·Annual Review of Pharmacology and Toxicology·Vincenzo SorrentinoJohan Auwerx
Mar 7, 2019·Nature Reviews. Rheumatology·Steven A Greenberg
Feb 25, 2017·European Journal of Neurology : the Official Journal of the European Federation of Neurological Societies·M JohariB Udd
Aug 28, 2020·International Journal of Molecular Sciences·Vered RazBaziel G M van Engelen
Mar 3, 2019·Autoimmunity Reviews·Gaëlle Dzangué-TchoupouOlivier Benveniste
May 30, 2021·Ultrasound in Medicine & Biology·Julio Brandao GuimaraesEdmar Zanoteli
Nov 13, 2021·Critical Reviews in Clinical Laboratory Sciences·Konstantinos I TsamisIoannis Sarmas

❮ Previous
Next ❯

Related Concepts

Related Feeds

Autoimmune Diseases

Autoimmune diseases occur as a result of an attack by the immune system on the body’s own tissues resulting in damage and dysfunction. There are different types of autoimmune diseases, in which there is a complex and unknown interaction between genetics and the environment. Discover the latest research on autoimmune diseases here.

Cell-Type-Specific Viral Vectors (ASM)

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cardiac Cachexia

Cardiac cachexia is a syndrome associated with the progressive loss of muscle and fat mass. It most commonly affects patients with heart failure and can significantly decrease the quality of life and survival in these patients. Here is the latest research on cardiac cachexia.

ALS: Transposon de-silencing

Transposon silencing is a form of transcriptional gene silencing. These gene silencing mechanisms are impaired in Amyotrophic lateral sclerosis (ALS). Here are the latest discoveries pertaining to transposon silencing and this disease.

Cell-Type Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Cachexia & Brown Fat

Cachexia is a condition associated with progressive weight loss due to severe illness. In cancer patients, it is proposed to occur as a result of tumor-induced energy wasting. Several proteins have been implicated in browning and depletion of white adipose tissue. Here is the latest research on cachexia and brown fat.

Cell-Type-Specific Viral Vectors

Viral vectors are used in biological research and therapy to deliver genetic material into cells. However, the efficiency of viral vectors varies depending on the cell type. Here is the latest research on cell-type-specific viral vectors.

Related Papers

Journal of Clinical Neuroscience : Official Journal of the Neurosurgical Society of Australasia
F L Mastaglia, Merrilee Needham
Annals of Neurology
R C GriggsL P Rowland
Nihon rinsho. Japanese journal of clinical medicine
Ken-ya Murata
© 2022 Meta ULC. All rights reserved